Agenda
Specific meetings can focus on any of the following aspects of the management of ART:
- Innovations in First-line ART for Diverse Patients
- State-of-the-Art Switch Strategies in Virologically Suppressed Patients
- Optimizing HIV Outcomes in Challenging Scenarios
- Cutting-Edge Concepts in HIV Care
- Expanding PrEP Uptake: Barriers and Solutions
The timing and agenda for each individual meeting is as follows:
- Welcome, CME information, and baseline outcomes questions (10 mins)
- Case 1 discussion followed by didactic slides (10-15 mins)
- Case 2 discussion followed by didactic slides (10-15 mins)
- Case 3 discussion followed by didactic slides (10-15 mins)
- Question and answer session, concluding outcomes questions (15-20 mins)
Events
Date / Time
Event Details
Faculty
Program Director
Joseph J. Eron, Jr., MD
Professor of Medicine and Epidemiology
University of North Carolina School of Medicine
Director, AIDS Clinical Trials Unit
University of North Carolina
Chapel Hill, North Carolina
Program Director
Jeffrey Kwong, DNP, MPH, AGPCNP-BC, ACRN, FAANP, FAAN, AAHIVS
Professor
Division of Advanced Nursing Practice
Rutgers School of Nursing
Newark, New Jersey
Nurse Practitioner
Gotham Medical Group
New York, New York
Program Director
Milena Murray, PharmD
Associate Professor
Department of Pharmacy Practice
Midwestern University College of Pharmacy, Downers Grove Campus
Downers Grove, Illinois
System-Level HIV/ID Clinical Pharmacist
Ambulatory Pharmacy
Northwestern Medicine
Wheaton, Illinois
Faculty
Roger Bedimo, MD, MS, FACP
Professor of Medicine
Division of Infectious Diseases
University of Texas Southwestern Medical Center
Section Chief
Division of Infectious Diseases
Department of Internal Medicine
VA North Texas Health Care System
Dallas, Texas
Faculty
Michelle S. Cespedes, MD, MS
Associate Professor of Medicine Division of Infectious Diseases
Icahn School of Medicine at Mount Sinai
New York City, NY
Faculty
Eric S. Daar, MD
Chief, Division of HIV Medicine
Harbor-UCLA Medical Center
Professor of Medicine
David Geffen School of Medicine at UCLA
Los Angeles, California
Faculty
Monica Gandhi, MD, MPH
Professor of Medicine
Division of HIV, Infectious Diseases, and Global Medicine
University of California, San Francisco
Medical Director
Ward 86 HIV Clinic
San Francisco General Hospital
San Francisco, California
Faculty
Gregory Huhn, MD, MPHTM
Professor of Medicine
Department of Infectious Diseases
Rush University Medical Center
Interim Chief
Division of Infectious Diseases
Cook County Health
Chicago, Illinois
![]()
Faculty
Dushyantha Jayaweera, MD
Professor of Medicine
Division of Infectious Diseases
Department of Medicine
University of Miami
Professor of Medicine
Attending Physician
Jackson Memorial Hospital
University of Miami Hospital and Clinics
Miami, Florida
Faculty
Princy N. Kumar, MD, FIDSA, MACP
Professor of Medicine and Microbiology
Chief, Division of Infectious Diseases and Travel Medicine
Senior Associate Dean of Students
Georgetown University School of Medicine
Washington, DC
Faculty
Aadia I. Rana, MD
Associate Professor of Medicine
Division of Infectious Diseases
The University of Alabama at Birmingham
1917 Clinic
Birmingham, Alabama
Faculty
Paul E. Sax, MD
Clinical Director
HIV Program and Division of Infectious Diseases
Brigham and Women's Hospital
Professor of Medicine
Harvard Medical School
Boston, Massachusetts
Faculty
Babafemi Taiwo, MBBS
Gene Stollerman Professor of Medicine
Chief, Division of Infectious Diseases
Northwestern University Feinberg School of Medicine
Chicago, Illinois
Faculty
Timothy J. Wilkin, MD, MPH
Professor of Medicine
Division of Infectious Diseases
Weill Medical College of Cornell University
New York, New York
Faculty
Darcy Wooten, MD
Associate Professor of Medicine
Division of Infectious Diseases and Global Public Health
Department of Medicine
University of California, San Diego
San Diego, California
Goal Statement
The goal of this activity is to improve learners’ competence in implementing optimal HIV treatment and prevention strategies through the appropriate use of contemporary ARV regimens.
Target Audience
This program is intended for physicians, registered nurses, physician assistants, pharmacists, and other healthcare professionals who provide care for patients with HIV infection.
Learning Objectives
Upon completion of this activity, participants should be able to:
- Integrate best practices in the evidence-based management of ART across the spectrum of ART experience
- Identify barriers to PrEP uptake and employ practical strategies to increase PrEP use among those for whom it is recommended
- Incorporate the latest data and expert insights on emerging innovative ARV treatment or prevention paradigms into the individualized care of persons with or at risk of HIV infection
- Appropriately counsel patients regarding the anticipated clinical role of new and investigational ART regimens
Accreditation
Joint Accreditation Statement
In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Physician Continuing Medical Education
Designation of Credit
CCO designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Continuing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.0 contact hour.
Continuing Pharmacy Education
CCO designates this continuing education activity for 1.0 contact hour (0.1 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number - UANs will be specific to each topic.
Type of Activity: Application
Upon successfully completing the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.
Disclosure of Conflicts of Interest
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.